CALABRESI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 55.236
AS - Asia 4.669
EU - Europa 3.577
SA - Sud America 691
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 8
Totale 64.251
Nazione #
US - Stati Uniti d'America 55.144
SG - Singapore 2.398
CN - Cina 934
UA - Ucraina 837
DE - Germania 574
BR - Brasile 572
HK - Hong Kong 550
RU - Federazione Russa 520
IE - Irlanda 468
VN - Vietnam 308
SE - Svezia 235
FR - Francia 229
IT - Italia 217
GB - Regno Unito 174
FI - Finlandia 169
KR - Corea 161
JP - Giappone 107
PL - Polonia 59
AR - Argentina 51
CA - Canada 40
IN - India 38
BD - Bangladesh 27
MX - Messico 27
NL - Olanda 24
ID - Indonesia 22
EU - Europa 19
TR - Turchia 17
EC - Ecuador 16
CL - Cile 14
IQ - Iraq 14
ZA - Sudafrica 14
KG - Kirghizistan 13
ES - Italia 11
SA - Arabia Saudita 11
MA - Marocco 10
UZ - Uzbekistan 10
VE - Venezuela 10
PK - Pakistan 9
AT - Austria 8
CZ - Repubblica Ceca 8
PY - Paraguay 8
UY - Uruguay 8
AU - Australia 7
BE - Belgio 7
LT - Lituania 7
DZ - Algeria 6
MY - Malesia 6
PH - Filippine 6
JO - Giordania 5
KE - Kenya 5
KZ - Kazakistan 5
PE - Perù 5
CH - Svizzera 4
DM - Dominica 4
IR - Iran 4
NG - Nigeria 4
NP - Nepal 4
RO - Romania 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
DK - Danimarca 3
GR - Grecia 3
JM - Giamaica 3
MT - Malta 3
PT - Portogallo 3
SV - El Salvador 3
BH - Bahrain 2
BO - Bolivia 2
CR - Costa Rica 2
EG - Egitto 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
LB - Libano 2
LV - Lettonia 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MF - Saint Martin 1
ML - Mali 1
Totale 64.243
Città #
Woodbridge 17.722
Wilmington 14.503
Houston 12.885
Fairfield 1.675
Ann Arbor 1.322
Singapore 1.048
Jacksonville 776
Ashburn 768
Seattle 629
Cambridge 574
Hong Kong 544
Dublin 468
San Jose 417
Chandler 408
Medford 327
Beijing 291
Santa Clara 207
The Dalles 192
Lawrence 160
New York 142
Zhengzhou 120
Mülheim 112
Los Angeles 104
Ho Chi Minh City 103
Menlo Park 102
Buffalo 86
Tokyo 83
Dearborn 82
Moscow 79
Hanoi 59
San Diego 56
São Paulo 50
Dallas 49
Kraków 46
Rome 42
Lauterbourg 40
Milan 39
University Park 39
San Mateo 37
Shanghai 34
Mcallen 32
Hefei 31
Guangzhou 30
Mountain View 29
Orem 29
Munich 27
Falls Church 26
London 26
Verona 25
Saint Petersburg 24
Nanjing 22
Redwood City 19
Rio de Janeiro 19
Detroit 18
Frankfurt am Main 18
Palo Alto 18
Montreal 17
Norwalk 17
Chicago 15
Redondo Beach 14
Atlanta 12
Brasília 12
Chennai 12
Monmouth Junction 12
North Bergen 12
Redmond 12
Da Nang 11
Nuremberg 11
San Francisco 11
Belo Horizonte 10
Brooklyn 10
Kunming 10
Nanchang 10
Salvador 10
Toronto 10
Warsaw 10
Biên Hòa 9
Columbus 9
Haiphong 9
Hangzhou 9
Indiana 9
Johannesburg 9
Council Bluffs 8
Dhaka 8
Jakarta 8
Manchester 8
Porto Alegre 8
Stockholm 8
Amsterdam 7
Brno 7
Brussels 7
Campinas 7
Can Tho 7
Jinan 7
Poplar 7
Tashkent 7
Boston 6
Cagliari 6
Curitiba 6
Denver 6
Totale 57.233
Nome #
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 567
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 549
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 547
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 527
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 518
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 506
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 504
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 497
Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis 490
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 480
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 477
Muscarinic IPSPs in rat striatal cholinergic interneurones 472
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 469
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 465
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 465
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 463
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 463
The Project for a Scientific Psychology (1895): a Freudian anticipation of LTP-memory connection theory 462
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 460
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 456
Synaptic transmission in the striatum: from plasticity to neurodegeneration 455
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 454
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 454
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 450
Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP 446
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine 446
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 445
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 444
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease 441
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 439
Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons 438
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 436
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine 436
NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum 434
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons 433
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia 433
Unilateral dopamine denervation blocks corticostriatal LTP 433
Synaptic plasticity in the ischaemic brain 432
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons 432
Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum 432
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 430
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity 430
Hyperkinetic disorders and loss of synaptic downscaling 430
Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons 429
Long-term synaptic depression in the striatum: physiological and pharmacological characterization 429
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 428
Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation 427
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism 427
Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons 427
Removing pathogenic memories: a neurobiology of psychotherapy 426
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine 426
Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity 424
Role of Ca2+ in striatal LTD and LTP 424
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons 423
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 423
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 422
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors 422
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study 421
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 421
Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity 420
Deficits of glutamate transmission in the striatum of experimental hemiballism 419
L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases 419
Dopaminergic control of synaptic plasticity in the dorsal striatum 419
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 419
Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors 418
The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia 418
Transmitter release associated with long-term synaptic depression in rat corticostriatal slices 418
NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease 416
Engagement of rat striatal neurons by cortical epileptiform activity investigated with paired recordings 416
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability 415
Tissue plasminogen activator is required for corticostriatal long-term potentiation 415
Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment 414
Pathological synaptic plasticity in the striatum: implications for Parkinson's disease 413
Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors 412
Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease 411
Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses 410
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors 409
Permissive role of interneurons in corticostriatal synaptic plasticity 409
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease 409
The modulation of dopamine receptors in rat striatum 408
SYNAPTIC PLASTICITY IN THE STRIATUM - ROLE OF GLUTAMATE AND DOPAMINE-RECEPTORS 408
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 406
Basic research in substantia nigra and ventral tegmental area: clinical implications 406
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 405
The modulation of calcium currents by the activation of mGluRs. Functional implications 405
Long-term potentiation and memory processes in the psychological works of Sigmund Freud and in the formation of neuropsychiatric symptoms 401
Chronic cocaine prevents depotentiation at corticostriatal synapses 400
Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery 399
Long-term Potentiation in the Striatum is Unmasked by Removing the Voltage-dependent Magnesium Block of NMDA Receptor Channels 399
NR2B subunit exerts a critical role in postischemic synaptic plasticity 398
Glutamate-triggered events inducing corticostriatal long-term depression 397
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum 396
Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease 396
Activation of metabotropic glutamate receptor subtype 1/protein kinase C/mitogen-activated protein kinase pathway is required for postischemic long-term potentiation in the striatum 396
Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum 395
Electrophysiology of dopamine in normal and denervated striatal neurons 392
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies 392
Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons 390
Acanthocytosis as a predisposing factor non-ketotic hyperglycemia induced chorea-ballism 388
Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses 386
Totale 43.401
Categoria #
all - tutte 128.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.190


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021469 0 0 0 0 0 0 0 0 0 0 343 126
2021/20221.282 35 71 35 98 16 201 34 51 72 195 38 436
2022/20231.437 190 77 27 138 84 423 157 80 93 4 135 29
2023/2024344 32 13 37 8 32 113 15 27 2 5 0 60
2024/20253.324 83 805 356 189 50 197 240 73 244 191 531 365
2025/20264.205 354 313 514 359 388 134 450 650 493 523 27 0
Totale 64.411